Specifically, we propose that SAB enhances the activity of the SLC7A11 and GPX4 proteins by binding to peroxiredoxin 5 (PRDX5) and boosting PRDX5's bioactivity in cisplatin‐induced AKI. The gene discussed is PRDX5; the disease is acute kidney injury.